Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Globe-trotting decision scientist seeks solutions to hepatitis B | News Center

Globe-trotting decision scientist seeks solutions to hepatitis B | News Center

Toy initially studied epidemiology, the branch of medicine focused on the prevalence and distribution of disease. But one of her professors got her hooked on mathematical modeling. She earned a PhD in public health at Erasmus University Medical Center in Rotterdam and became a decision scientist.

“A decision scientist helps to pick up loose ends when decisions have to be made. They consider, among other things, the costs associated with various alternatives,” Toy said. “For instance, when faced with cancer treatment alternatives, what is the best alternative for the population and the person?”

As a graduate student, Toy looked at the public health impact of antiviral therapy for hepatitis B. Her work resulted in public health policy changes in the Netherlands and in Turkey. After completing her PhD, Toy accepted a fellowship at Harvard to study international health and spent a good deal of time in China doing research. She focused on several cost-effective interventions for chronic hepatitis B infection and became a recognized expert, publishing her work in prominent journals. China also enacted health policy changes because of Toy’s work, which provided policymakers the evidence they needed to procure low-cost drugs for a national viral hepatitis treatment program.

‘What if?’

To build her cost-effectiveness models, Toy starts with figuring out how many lives can be saved with a particular treatment, and then she plays with variables contributing to costs to see under what conditions the treatment will be cost-effective or cost-saving. She does this by asking, “What if?” If there is a 10 percent prevalence rate of a disease, but most of it is seen in adult males, what if 90 percent of those men were screened for the disease? What if 80 percent of those who had the disease got treated? She said she always has to think of the future to include factors that may not be relevant now. A cure might be within reach, or bioindustry costs may change, or the political climate could impact a number of variables, she said.

We need simplified tools to communicate complex information to patients.

One of the biggest challenges of being a decision scientist is getting access to the specific data sets needed to build a particular model, Toy said. “Sometimes physicians or researchers or drug companies just don’t want to share data with you,” she said. Now that she has established herself as a leader in the field, it’s easier to develop collaborations. 

Toy came to Stanford in 2013 as a postdoctoral scholar to work with Samuel So, MD, executive director of the Asian Liver Center, which seeks to address the disproportionately high prevalence of chronic hepatitis B and liver cancer in Asians and Asian-Americans. Toy traveled to the Philippines, Mongolia, Indonesia and Australia, among other places, to contribute to the center’s outreach efforts and to gather information for the WHO.

The best part about being a decision scientist, Toy said, is being able to create user-friendly tools that health ministries can use to inform decisions affecting health policy. She built a model in a spreadsheet that was made freely available to health ministries and is now available online. She recently gave a two-day workshop in Indonesia to teach health care leaders how to use it and how to enter and adjust variable amounts to lower the cost of health care. “It also serves as an outreach tool,” she said. “By emphasizing that hepatitis B is a serious disease, this sort of outreach can impact health policy.”

Basis of a national strategy

Toy was commissioned by the National Academies of Sciences, Engineering and Medicine to model the potential impact of improving chronic hepatitis B patient care and treatment in the United States. “I was very humbled that I could be asked to do such a thing,” she said. “It made me very happy and proud to be calling the U.S. my home. It really made me feel like I was at home.” Her study, published in March of 2017, concluded that it was feasible to eliminate the public health problem of hepatitis B in the country by 2030 and formed the basis of a national strategy that changed health care policy in the United States.

She was invited by the Centers for Disease Control and Prevention to present her hepatitis B model the following month at the viral hepatitis summit in Atlanta. Her colleagues praised her ability to make such a complicated model easy to understand in the presentation. The conference was streamed live. Her family and friends were thrilled to be able to watch from over 4,000 miles away. “They took so many screenshots!” Toy said.

Looking to the future, Toy is interested in expanding her work to have a broader reach and developing applications that haven’t been explored yet. She’s working on a prediction model of liver cancer for patients to use. Nothing like that is currently available. 

“By entering basic data such as age, gender and blood test results, the tool will calculate the probability of liver cancer in a given amount of time and can potentially guide the patient to follow recommended monitoring and treatment,” Toy said. “We need simplified tools to communicate complex information to patients.” 

It will be a collaborative effort, drawing on the expertise of clinical psychologists, user-experience designers, biomedical informaticists and decision scientists. “This is using public outreach on an individual level to affect patient outcomes,” Toy said. “Putting these powerful tools in the hands of patients has the potential to make a huge impact on behavior change.” 

Does Toy use decision models in her personal life? When she was in Boston, she used modeling for decision-making in life just for fun with a few colleagues, she said. “We would try to answer a question in our personal life and give weights/utilities to some of these states to predict an outcome.” She doesn’t do that anymore but does apply the pragmatic part of modeling to her life. “I used to be more spontaneous with decision-making, but lately I am trying to take my time,” she said.

Tagged with:

About author

Related Articles